Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - Youngevity International, Inc. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of
Report (date of earliest event reported): February 11, 2020
YOUNGEVITY INTERNATIONAL, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
001-38116
|
|
90-0890517
|
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File No.)
|
|
(IRS
Employer Identification No.)
|
2400 Boswell Road, Chula Vista, CA 91914
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (619) 934-3980
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
|
Title
of each class
|
Trading
Symbol(s)
|
Name
of each exchange on which registered
|
|
Common
Stock
|
YGYI
|
The
Nasdaq Capital Market
|
|
Series
D Preferred Stock
|
YGYIP
|
The
Nasdaq Capital Market
|
Indicate
by check mark whether the registrant is an emerging growth company
as defined in in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this
chapter).
Emerging
growth company ☐
If an
emerging growth company, indicate by checkmark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange
Act. ☐
Item 5.02. Departure of Directors or Certain officers; Appointment
of Certain Officers; Compensatory Arrangements of Certain
Officers.
On
February 11, 2020, in order to maintain compliance with the
corporate governance requirements of The Nasdaq Capital Market, and
specifically Listing Rule 5605(b) which provides that a listed
company’s board of directors shall be comprised of a majority
of independent directors, Michelle Wallach and Richard Renton, two
non-independent members of the Board of Directors of Youngevity
International, Inc. (the “Company”), resigned as
members of the Board of Directors of the Company. The notices of
resignation provided by each director specifically stated that the
resignations were not the result of any disagreement with the
Company on any matter related to the Company’s operations,
policies or practices.
Item 9.01 Financial Statements and
Exhibits.
|
(d)
|
Exhibits.
|
|
|
|
|
|
Exhibit 99.1 Press Release issued by Youngevity International,
Inc. dated February 13, 2020.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
YOUNGEVITY
INTERNATIONAL, INC.
|
|
|
|
|
Date:
February 13, 2020
|
By: /s/
David Briskie
|
|
|
Name:
David Briskie
|
|
|
Title:
President and Chief Financial Officer
|